NASDAQ: CNTX
Context Therapeutics Inc Stock Ownership - Who owns Context Therapeutics?

Insider buying vs selling

Have Context Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CNTX insiders and whales buy or sell their stock.

CNTX Shareholders

What type of owners hold Context Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Martin A. Lehr1.18%1,079,891$373.64kInsider
Alex C. Levit0.09%81,983$28.37kInsider
Jennifer Lynn Minaiazary0.09%80,010$27.68kInsider
Evan G. Dick0.06%56,373$19.51kInsider
Tarek Sahmoud0.01%10,000$3.46kInsider
Deep Track Capital LP0.01%7,419$2.57kInstitution
Nextech Invest Ltd0.01%7,419$2.57kInstitution
Deetra0.01%7,419$2.57kInstitution
Nextec0.01%7,419$2.57kInstitution
Soleus Capital Management LP0.01%7,063$2.44kInstitution

1 of 3

CNTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTX0.07%1.43%
CVM0.01%52.55%Net BuyingNet Buying
QNTM0.01%0.00%
QNCX0.00%100.00%Net Selling
ATYR0.04%16.45%Net Buying

Context Therapeutics Stock Ownership FAQ

Who owns Context Therapeutics?

Context Therapeutics (NASDAQ: CNTX) is owned by 0.07% institutional shareholders, 1.43% Context Therapeutics insiders, and 98.50% retail investors. Martin A. Lehr is the largest individual Context Therapeutics shareholder, owning 1.08M shares representing 1.18% of the company. Martin A. Lehr's Context Therapeutics shares are currently valued at $352.04k.

If you're new to stock investing, here's how to buy Context Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.